CClinicalTrials.gg
CompletedNCT00645684Updated Mar 28, 2008

Clinical Use of an Absorbable Coated Suture Material in Surgery (Safil)

A Phase 4 interventional study of Gastrointestinal Anastomosis in Gastrointestinal Diseases, Laparotomy and Anastomosis, Surgical, sponsored by Aesculap AG. Completed at 3 sites in Hungary. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2008-03-28.

Sponsored by Aesculap AG · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose is to test a coated polyglycolic acid multifilament suture in gastrointestinal surgery as part of a controlled randomized single blinded parallel group trial. The applicability and safety of the strand material used in two suture techniques (2-layer suture technique vs. 1-layer running) are to be tested on the basis of handling characteristics, the operative time consumed for the construction of the 1st anastomosis, the average time of the hospital duration for both patient groups, and the frequency of postoperative complications after discharge, 1 month and a maximum of 3-4 months. The used suture units are counted and the length of sutures determined which will be an indirect measurement of the costs of suture material for the two techniques.

02

Conditions studied

  • Gastrointestinal Diseases
  • Laparotomy
  • Anastomosis, Surgical
  • Absorbable, Coated Sutures

Keywords

  • Gastrointestinal Anastomosis
  • Multicentre
  • Randomized controlled single-blind study
  • synthetic, absorbable, braided and coated suture material
  • Laparotomy
03

In context

Gastrointestinal Diseases

628 studies on the registry are indexed under Gastrointestinal Diseases; 128 are open to participants now.

This study's enrollment of 210 is above the median of 77 across 422 interventional studies indexed under Gastrointestinal Diseases.

Browse Gastrointestinal Diseases studies →

Lead sponsor

Aesculap AG is the lead sponsor of 104 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patients of both sexes, undergoing a gastrointestinal hand made one-layer running (A) or two-layer (B) anastomotic procedure where the use of synthetic absorbable surgical suture material is indicated.
  • Written consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Emergency patients that cannot be properly informed about the clinical trial and cannot give their written consent
  • Pregnancy or lactation period
  • Patients suffering from a diffuse purulent peritonitis or generalized diseases, which can have consequences for the healing of the asnastomosis (e.g. ubalanced diabetes, progressed uremia, massive hypoproteinaemia, sever jaundice, generalized intraabdominal tumor metastases, severe tumorous cachexia, severe avitaminosis, chronic liver disease.
  • Patients who are undergoing a therapeutic procedure, which can have consequences for the healing of the anastomosis (e.g. treatment with corticosteroids or cytostatics, local radiation in the operating area)
  • Laparoscopial Procedures
  • Patients who are not willing to cooperate and legally incapacitated people
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
210 participants (actual)

Study arms

  • Experimental
    A

    one layer running suture technique

    Procedure: Gastrointestinal Anastomosis

  • Experimental
    B

    two-layer suture technique

    Procedure: Gastrointestinal Anastomosis

Interventions

  • ProcedureGastrointestinal Anastomosis

    Gastrointestinal Anastomosis with synthetic, absorbable, coated suture material using two different suture-techniques

    Also known as: SAFIL®: is a mid-term braided and coated synthetic absorbable suture made of, pure polyglycolic acid.

06

What researchers measure

Primary outcomes

  1. Frequency of postoperative Complications

    Time frame: discharge, 1 month and a maximum of 3-4 months

Secondary outcomes

  1. handling characteristics

    Time frame: intraoperative

  2. Operation time to construct the first anastomosis

    Time frame: intraoperative

  3. length of hospitalization

    Time frame: postoperative

  4. costs of suture material

    Time frame: intraoperative

07

Study locations

3 sites
  • Bugat Pal Korhaz, Sebeszeti Osztaly
    Gyöngyös, Hungary
  • B.-A.-Z. Megyei Korhaz, Sebeszeti Osztaly
    Miskolc, Hungary
  • Medical School of University Pecs
    Pecs, Hungary
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 28, 2008, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT00645684
Lead sponsor
Aesculap AG
First posted
Mar 28, 2008
Start date
Apr 1998
Primary completion
Sep 2001
Completion
May 2002
Last update
Mar 28, 2008

Study contacts

György Weber, MD, PhD
principal investigator · Medical School of University Pecs, Hungary

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2008. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion